Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 13/20 | 0.54 |
| ▸ | PPARA | Q07869 | 12/20 | 0.54 |
| ▸ | LTB4R | Q15722 | 1/20 | 0.51 |
| ▸ | PPARD | Q03181 | 5/20 | 0.50 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.46 |
| ▸ | ELANE | P08246 | 2/20 | 0.44 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24648565 | 0.94 | PPARG (0.56) | PPARGPPARALTB4RPPARDMCHR1 | |
| SCHEMBL30020306 | 0.94 | PPARG (0.56) | PPARGPPARALTB4RPPARDMCHR1 | |
| SCHEMBL24648593 | 0.85 | PPARG (0.57) | PPARGPPARALTB4RPPARD | |
| SCHEMBL24648542 | 0.84 | CYP1A2 (0.52) | PPARGPPARAELANE | |
| SCHEMBL30021104 | 0.80 | PPARG (0.59) | PPARGPPARALTB4RPPARD | |
| SCHEMBL24648603 | 0.80 | PPARG (0.59) | PPARGPPARALTB4RPPARD | |
| SCHEMBL24648579 | 0.77 | F10 (0.48) | PPARGPPARA | |
| SCHEMBL6936861 | 0.76 | PPARA (0.59) | PPARGPPARALTB4RPPARD | |
| SCHEMBL6938382 | 0.75 | PPARG (0.64) | PPARGPPARALTB4RPPARDELANE | |
| SCHEMBL10927028 | 0.75 | SMN1; SMN2 (0.53) | LTB4R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022221960-A1 | COMPOUNDS FOR TREATING PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) MEDIATED DISEASES OR CONDITIONS | Medipure Pharmaceuticals Inc. (CA) | 2022-10-27 | — | — | WO | disclosed |